World News: 13:31 GMT Monday 11th February 2019. [OptimizeRx Corporation via Globe Newswire via SPi World News]
ROCHESTER, Mich., Feb. 11, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, announced today its initial findings from a physician survey focused on prescription drug costs. The Drug Cost Survey yields insights into physician perspectives on the affordability of prescription drugs and patient adherence to prescription regimens.
“The vast majority of Americans cited the costs of prescription drugs as ,” said Miriam Paramore, president of OptimizeRx. “Further, it is widely studied that affordability is a primary factor contributing to medication non-adherence. We wanted to go directly to physicians and gauge their opinions on the matter: How do they view their role in discussing healthcare costs? Do patients routinely ask about costs? These questions and more were included in our survey.”
Initial findings from the OptimizeMDs Drug Cost Survey showed that:
Patients and providers want to discuss the cost of prescriptions, and providers help patients look for savings opportunities through co-pay coupons and other patient assistance programs. However, both parties are ham-strung by the lack of information showing total drug price – including the true patient out-of-pocket price. Supplemented by other industry findings, the results from OptimizeRx’s survey illustrate the gap in communications among the stakeholders involved in or affected by drug pricing: the party who make the drugs and set the initial price (pharmaceutical manufacturers), the party who sets the price for a benefit plan (payers), the party who prescribes the drugs and need to know the price (providers) and those have to take/adhere the drugs and pay its price (patients).
Continued Paramore: “At OptimizeRx, we are committed to fill the communications gap between patients, providers and the pharmaceutical industry. By going to the physicians directly through this first survey, we learned a lot about how we, as an industry, can better communicate to address drug affordability and adherence.”
Additional results from this survey will be released throughout the coming months. OptimizeRx plans to facilitate a corollary consumer survey to gauge their perspectives on financial discussions, prescription affordability and medication adherence.
Conducted between January 9 and 14, 2019, the survey included responses from 642 physicians across a variety of specialties, practice and/or hospital sizes and locations across the United States. It was the first to be executed through , a multi-specialty physician panel created by OptimizeRx to improve the effectiveness of digital communication between pharma/life sciences and physicians at the point-of-care. OptimizeMDs is one of the brand support services available to pharmaceutical manufacturers.
For more information on OptimizeRx or its OptimizeMDs physician panel, visit . To download the initial two-page summary, visit .
Globe Newswire: 13:31 GMT Monday 11th February 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.